We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Stockholm, Sweden

ESTRO 2026

Session

Saturday
May 16
15:15 - 16:15
K11
Mixed clinical sites
Gitte Fredberg Persson, Denmark;
Łukasz Kuncman, Poland
Poster Discussions
Clinical
15:15 - 16:15
Phase III randomized trial comparing Preoperative versus Postoperative Hypofractionated radiosurgery for large brain metastases. Support Trial
Pierina Navarria, Italy
-4799
15:15 - 16:15
Second interim analysis of the phase II trial of intraoperative radiotherapy with INTRABEAM after surgical resection of brain metastases (NCT05084092)
Anna Lucas , Spain
-4477
15:15 - 16:15
Spatially Fractionated Radiotherapy (SFRT) for Bulky Tumors: A Systematic Review of Clinical Outcomes and Dosimetric Variability
Rocco Mottareale, Italy
-1899
15:15 - 16:15
Optimization of Patient-Reported Quality of Life Data Collection in Proton Therapy: The Power Registry Experience
Chiara Lorubbio, Italy
-4219
15:15 - 16:15
Patient characteristics and treatment patterns in oligorecurrent prostate cancer treated on MR-Linac: insights from the international MOMENTUM study
Kristine Skovly Nielsen, Denmark
-2735
15:15 - 16:15
START-MET: A phase III randomized trial of SBRT plus standard of care in oligometastatic hormonecastration-sensitive oligometastatic prostate cancer
Antonio Jose Conde Moreno, Spain
-1913
15:15 - 16:15
Reducing treatment fractions by personalized fractionation with online adaptive radiotherapy: a phase II study (STEAL-3)
Erik van Lieshout, The Netherlands
-2057
15:15 - 16:15
Role of salivary S100A7 as prognostic biomarker in Oral Squamous Cell Carcinoma (OSCC)
Sushmita Chakrabarti, India
-2807